HOME
WHO IS BDA
BDA DELIVERS
KEY PROJECTS
REFERENCE WORK 
PRINCIPALS & ASSOCIATES
CONTACT US 
Business Development Advisors
Reference Work

Transgenomic, Inc. is an analytical instrument manufacturer specializing in the analysis of DNA. The company launched its DNA chromatography instrumentation in 1997 for the purpose of separating DNA fragments and analyzing their mutational variability, or Single Nucleotide Polymorphisms (SNPs). The company has found utility for its instrumentation as a clinical diagnostics methodology for the detection of certain genetic traits useful as prognostic indicators in the treatment of cancer. And, in further application of its technology analysis of RNA fragments has started to lead to increased application of its instrumentation. It has branched out into synthetic DNA chemistries and is a GMP contract manufacturer of synthetic DNA oligonucleotides and synthetic DNA components for other biotechnology companies including ISIS . The company had an initial round of funding 1997 a second round in 1998 and did an IPO.

How Sourced: CEO

Our involvement: Plan & Strategy, capital leads, banker/attorney management, project management